CN110322963A - A kind of newborn's Inherited Metabolic Disorders determination method, apparatus and system - Google Patents
A kind of newborn's Inherited Metabolic Disorders determination method, apparatus and system Download PDFInfo
- Publication number
- CN110322963A CN110322963A CN201910597264.2A CN201910597264A CN110322963A CN 110322963 A CN110322963 A CN 110322963A CN 201910597264 A CN201910597264 A CN 201910597264A CN 110322963 A CN110322963 A CN 110322963A
- Authority
- CN
- China
- Prior art keywords
- metabolic disorders
- newborn
- inherited metabolic
- index
- interpretation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000016245 inborn errors of metabolism Diseases 0.000 title claims abstract description 86
- 208000015978 inherited metabolic disease Diseases 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims abstract description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 54
- 201000010099 disease Diseases 0.000 claims abstract description 53
- 238000012360 testing method Methods 0.000 claims abstract description 41
- 238000004458 analytical method Methods 0.000 claims abstract description 30
- 238000001514 detection method Methods 0.000 claims description 32
- 230000002159 abnormal effect Effects 0.000 claims description 11
- 238000010241 blood sampling Methods 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 9
- 238000013480 data collection Methods 0.000 claims description 9
- 235000003715 nutritional status Nutrition 0.000 claims description 9
- 230000005856 abnormality Effects 0.000 claims description 8
- 238000012216 screening Methods 0.000 claims description 8
- 238000010835 comparative analysis Methods 0.000 claims description 5
- 230000004060 metabolic process Effects 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 238000003908 quality control method Methods 0.000 claims description 4
- 206010061993 Haemorrhage neonatal Diseases 0.000 claims description 3
- 230000002547 anomalous effect Effects 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 238000011160 research Methods 0.000 claims description 3
- 230000009885 systemic effect Effects 0.000 claims description 3
- 210000001113 umbilicus Anatomy 0.000 claims description 3
- 238000012952 Resampling Methods 0.000 claims description 2
- 230000037353 metabolic pathway Effects 0.000 claims description 2
- 238000012502 risk assessment Methods 0.000 claims description 2
- 230000007717 exclusion Effects 0.000 claims 1
- 238000001819 mass spectrum Methods 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 9
- 238000013473 artificial intelligence Methods 0.000 abstract description 3
- 208000030159 metabolic disease Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- -1 immunocyte C4 Chemical compound 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 1
- 102000013658 Carnitine Acyltransferases Human genes 0.000 description 1
- 108010051527 Carnitine Acyltransferases Proteins 0.000 description 1
- 206010050215 Carnitine palmitoyltransferase deficiency Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 108700016447 Hydroxyprolinemia Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010062018 Inborn error of metabolism Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 208000015439 Lysosomal storage disease Diseases 0.000 description 1
- 208000030162 Maple syrup disease Diseases 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- UKFXDFUAPNAMPJ-UHFFFAOYSA-N ethylmalonic acid Chemical compound CCC(C(O)=O)C(O)=O UKFXDFUAPNAMPJ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000009395 genetic defect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000012595 hydroxyprolinemia Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 208000024393 maple syrup urine disease Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention proposes a kind of newborn's Inherited Metabolic Disorders determination methods, apparatus and system, computer system is created, disease database, the interpretation mode that doctor combines, interpretation more fast and accurately can be carried out to newborn's Inherited Metabolic Disorders tandem mass spectrum testing result and provide accurate conclusion, entire workflow realizes comprehensive data, interpretation process is enabled to be easier to trace to the source and later period Comparison Study repeatedly, it can greatly avoid that retrospective analysis can not be carried out because the artificial interpretation later period forgets, this system realizes the automation of higher degree using the mode of man-computer cooperation, greatly reduce the investment of human cost, with increasing for data volume, and system is continued to optimize, the interpretation of Artificial intelligence is possibly even realized in later newborn's Inherited Metabolic Disorders tandem mass spectrum testing result interpretation.
Description
Technical field
The present invention relates to field of medical equipment, especially a kind of newborn's Inherited Metabolic Disorders determination method, device and
System.
Background technique
Inherited Metabolic Disorders be because maintain body eubolism necessary to certain enzymes being made of polypeptide and (or) albumen, by
Genetic defect occurs for body, carrier and membrane pump biosynthesis, that is, caused by the gene mutation for encoding this kind of polypeptide (albumen)
Disease, also known as hereditary metabolic disorder or inborn error of metabolism.
The annual newborn population in China is about between 1,600 ten thousand to 2,000 ten thousand, and wherein Inherited Metabolic Disorders infant is up to 40 ten thousand to 50
Ten thousand, the birth of a large amount of Inherited Metabolic Disorders children brings huge burden for society and family, will certainly seriously affect country
Politics, economic, humane development strategy.Since China is national and medical personnel understands the knowledge of Inherited Metabolic Disorders
Very little, understanding is insufficient, and China proposed the concept of neonatal screening since 1981, promotes in legislation in 1994, using law
Form accelerate universal process.
In the extension process of many years, for Inherited Metabolic Disorders detection usually still: detection department is according to Testing index
Measured value provide examining report, by clinician according to examining report carry out Diseases diagnosis.But Inherited Metabolic Disorders are many kinds of, so far
The Inherited Metabolic Disorders type that the present has found is more than 3000 kinds.There is number using the Inherited Metabolic Disorders index of tandem mass spectrometry detection simultaneously
As many as ten, because individual difference will appear hundreds of different testing result combination, and then represent different classes of heredity metabolism
Different risks sick or that may be present.Different clinicians is not only different to Inherited Metabolic Disorders degree of understanding, Er Qieqi
The Inherited Metabolic Disorders type grasped also is not quite similar, if only passing through by veteran laboratory physician or clinician
Comparative analysis obtains correct conclusion from hundreds of conclusion repeatedly, not only takes time and effort but also limitation is very strong, and experience is insufficient
Doctor be unable to complete the accurate interpretation of its result.
Documents CN201710170285.7 discloses a kind of neonatal hereditary diease metabolic disease screening method, and this method is
It will test sample to be compared with the achievement data in medical data base, judge index in the detection sample and medical data base
Whether data match, if so, the screening data of the corresponding Inherited Metabolic Disorders of the matched achievement data are exported, if it is not, defeated
Non- illness out.There are two problem, problems one: although the judgement for alleviating clinician from a kind of degree is strong for the documents
Degree, but documents CN201710170285.7 output result is two kinds: illness or not illness, output result is too dogmatic,
Disease event can not be described accurately very much.A kind of such as Inherited Metabolic Disorders index of different role by multiple collectively forms, but
It is only that wherein some Indexes Abnormality or multiple auxiliary characteristics not played a decisive role are abnormal, this can not represent infant and centainly suffer from
Disease.Problem two: specifically how this database is established.
It can be seen that in the prior art, although part body has been equipped with brief Inherited Metabolic Disorders tandem mass spectrum
Examining report system, but it is to carry out simplicity of explanation to Testing index in the comparison analysis of not large database concept,
Interpretation result is not plain professional, is very easy to error.
Summary of the invention
To solve the above-mentioned problems, the invention proposes a kind of newborn's Inherited Metabolic Disorders determination method, the sides
Method includes the following steps: S1: obtaining sample data；S2: distinguishing according to sample data, if sample data exception, then holds
Row step S3；If sample data is normal, step S6 is executed；S3: according to each index in all kinds of Inherited Metabolic Disorders metabolic pathways
Effect degree carries out first step classification, obtains first time classification results；S4: multi objective joint risk assessment classification is carried out, is obtained
Second of classification results；S5: comprehensive first time classification results and second of classification results provide final classification of diseases result；
S6: terminate.
It include, by Quality Control Analysis method, analyzing sample data in the S1, if sample data does not conform to
Lattice then carry out resampling or reinspection, otherwise enter step S2.
The specific implementation of the S2 are as follows:
S21: the index for influencing Inherited Metabolic Disorders and the factor index that normal interpretation may be influenced are read；
S22: differentiating whether the index in S21 is all normal, if all normal, is determined as that index is normal or probability
It is very low, disease is not prompted, step S6 is executed；Otherwise, it is extremely suspicious that Inherited Metabolic Disorders are regarded as, execute step S3.
The specific implementation of the S3 are as follows:
S31: certain Inherited Metabolic Disorders being had confirmed that according to clinical research are mainly caused by what Indexes Abnormality, screening and the something lost
Pass on relevant index of declining office, invitation, etc. on account of illness；
S32: distinguishing the effect degree of index in the metabolic process, and the first time point of data is carried out according to the classification
Class.
The index to play a major role if it exists is raised and lowered, then it is assumed that results abnormity occurs very related to disease.Again
First time classification results are determined in conjunction with Indexes Abnormality degree and Clinical signs；Otherwise, step S4 is executed.
Specifically, Inherited Metabolic Disorders refer to a kind of hereditary disease for having metabolic function defect, mostly single gene inheritance disease, including
Metabolized macromolecules class disease (such as lysosomal storage disease (thirties kinds of diseases), mitochondriopathy) and metabolism small molecule class disease are (such as
The metabolic disorders such as amino acid, organic acid, fatty acid related disease).A part of cause of disease of Inherited Metabolic Disorders is caused by gene genetic, also
Some is that the gene mutation day after tomorrow causes.According to clinical research, with Inherited Metabolic Disorders highly relevant index occurs for confirmation, and
By these index typings, our database is used for interpretation, import detection data be in being carried out to the degree of risk of disease, severe
Interpretation.
The specific implementation of the step S4 are as follows:
In the whether judgement for being Inherited Metabolic Disorders, other indexs in addition to index highly relevant in step S3 continue and are
System disease database compare and analyze judgement, it is antenatal in combination with mother, produce when health and nutritional status, newborn take a blood sample
When disease and nutrition condition carry out accurate interpretation.If abnormal index and mother it is antenatal, produce when health and nutritional status, newborn
Nutritional status when blood sampling is related, and prompt is little with hereditary metabolic disorders correlation, is judged as that abnormal prompt disease probability is low；
If situation when excluding mother and newborn's blood sampling is abnormal there are still there is disease indicators, and its anomalous variation is little, then is judged as
It may be slight Inherited Metabolic Disorders, can be paid close attention to or be intervened ahead of time.
Preferably, in the step S1, pass through the sample data of neonatal bleeding of the umbilicus or vola blood.
Preferably, it in the step S6, before end, is provided accordingly according to interpretation result and inspection person's clinical information
It is recommended that and generating report.
Preferably, newborn's Inherited Metabolic Disorders test and analyze device and carry out newborn's something lost using foregoing method
Pass on detection and analysis of declining office, invitation, etc. on account of illness.
Preferably, newborn's Inherited Metabolic Disorders testing and analysis system includes data collection station, newborn's heredity generation
It declines office, invitation, etc. on account of illness and tests and analyzes device；Newborn's Inherited Metabolic Disorders test and analyze device and include data server, analysing terminal, show eventually
End；It is sequentially connected between the data collection station, the data server, the analysing terminal and the display terminal, number
It include data input module and pattern detection module according to acquisition terminal；Data server stores newborn's information bank and disease data
Library；Analysing terminal is generated according to detection data and is reported for obtaining detection data from data server；Display terminal is for showing
Show the examining report of generation；Newborn's Inherited Metabolic Disorders test and analyze device and carry out newborn using foregoing method
Inherited Metabolic Disorders test and analyze.Preferably, newborn's Inherited Metabolic Disorders testing and analysis system include feedback terminal, described point
Electric signal between terminal and the feedback terminal is analysed to connect；Feedback terminal is lost for obtaining Inherited Metabolic Disorders prediction result, feedback
Pass on actual result of declining office, invitation, etc. on account of illness.
The beneficial effects of the present invention are: 1, created computer system, disease database (big data), doctor combine
Interpretation mode, more fast and accurately newborn's Inherited Metabolic Disorders tandem mass spectrum testing result can interpretation and provide
Accurate conclusion.2, disease database covers more than ten ten thousand testing results, confirmed cases also with the time it is progressive increasingly
It is more, so that the interpretation of result can be more and more accurate, it is eventually striking to accurate interpretation；Have for corresponding Conventional wisdom interpretation very big
Supplement and improvement.3, conclusion suggestion is to be conferred to draft jointly by numerical digit authoritative expert, and professional degree authority is higher, can be very big
Limit avoids the omnifarious suggestion that the artificial subjective factor because of different people provides, and brings puzzlement to subsequent interpretation.
4, this system can greatly reduce the throwing of human cost due to high degree of automation, and using the Pattern completion of man-computer cooperation
Enter, so that the workload for needing 5-10 doctor to complete, can be completed by 2-3 people's coupled system.5, complete due to process
Face data enables interpretation process to be easier to trace to the source and later period Comparison Study repeatedly, can greatly avoid because manually sentencing
The later period is read to forget and retrospective analysis can not be carried out.6, later newborn with increasing for data volume and continuing to optimize for system
The interpretation of Artificial intelligence is possibly even realized in youngster's Inherited Metabolic Disorders tandem mass spectrum testing result interpretation.
Detailed description of the invention
Fig. 1 is system construction drawing；
Fig. 2 is the flow chart of the first subseries interpretation；
Fig. 3 is the flow chart of the second subseries interpretation.
Specific embodiment
For a clearer understanding of the technical characteristics, objects and effects of the present invention, this hair of Detailed description of the invention is now compareed
Bright specific embodiment.
As shown in Figure 1, a kind of newborn's Inherited Metabolic Disorders testing and analysis system, loses comprising data collection station, newborn
Passage, which is declined office, invitation, etc. on account of illness, tests and analyzes device；It includes data server, analysing terminal, display that newborn's Inherited Metabolic Disorders, which test and analyze device,
Terminal；It is sequentially connected between the data collection station, the data server, the analysing terminal and the display terminal,
Data collection station includes data input module and pattern detection module；Data server stores newborn's information bank and disease number
According to library；Analysing terminal is generated according to detection data and is reported for obtaining detection data from data server；Display terminal is used for
Show the examining report generated.Newborn's Inherited Metabolic Disorders testing and analysis system includes feedback terminal, the analysing terminal
Electric signal is connect between the feedback terminal；Feedback terminal feeds back heredity metabolism for obtaining Inherited Metabolic Disorders prediction result
Sick actual result.
Data collection station includes data input module and pattern detection module.Data input module is used for will be neonatal
Essential information and health and fitness information input system, perfect information library.Pattern detection module is used for according to neonatal bleeding of the umbilicus or vola
Blood obtains detection data, (connects sample according to newborn's Inherited Metabolic Disorders tandem mass spectrum testing process, generates experimentai batches, sample inspection
Survey, experiment is completed) process on line is completed, and the detection data that will acquire imports data server.Mass spectrum (the Mass
Spectrum so that sample to be tested molecule is gasified, with the beam bombardment gaseous molecular with certain energy, it is made to lose an electricity
Son and become positively charged ion, ion is also possible to fragment into various fragment ions, and all cations are in electric and magnetic fields
It is arranged successively under comprehensive function by mass-to-charge ratio (m/z) size and obtains spectrogram, for detection compound structure (qualitative) and mixed
Object composition (quantitative) is closed, it is tandem mass spectrum that two or more mass spectrums, which link together,.Tandem mass spectrometry is for blood sample
Originally there is certain requirement, it is desirable that blood sampling time carries out after 72 hours and 6 times or more milk of having enough preferably after baby due, mainly
Because if baby does not eat or do not take in enough milk, the concentration of phenylalanine in blood is relatively low, and when detection easily leads to false yin
Property, while blood sampling can avoid the opportunity of physiological thyroid-stimulating hormone rising after birth 72 hours, reduce thyroid hypofunction
The false positive of screening, and the false negative of TSH rising delay infant can be prevented, the blood sampling feelings of data input module typing can be passed through
Condition ensures that blood sample is met the requirements.
Data server stores newborn's information bank and disease database.Newborn's information bank stores neonatal basic letter
Breath, health and fitness information and detection data associated therewith, neonatal essential information and health and fitness information specifically include date of birth
Phase, gender, childbirth options, weight, disease treatment situation, mother's pregnancy period situation, blood sampling situation etc..Disease database storage and something lost
Decline office, invitation, etc. on account of illness relevant indication information and confirmed cases information are passed on, the index includes alanine Ala, leucine
Leu Ile Pro-OH, immunocyte C4, oleic acid C18:1 etc., leucine Leu Ile Pro-OH and maple syrup urine disease
It is related with hydroxyprolinemia, immunocyte C4 and isobutyryl glycinuria, ethyl malonic acid encephalopathy, short chain acyl coacetylase
Dehydrogenase Deficiency is related, oleic acid C18:1 and II type of Carnitine palmitoyltransferase deficiency disease, carnitine-fatty acyl carnitine translocase
Deficiency disease is related, and the indication information includes the corresponding relationship of specific targets and Inherited Metabolic Disorders.Disease database is currently covered
More than 10 ten thousand testing results, and confirmed cases can also gradually increase, so that the interpretation of result can be more and more accurate, it is final real
Now accurate interpretation has very big supplement and improvement for Conventional wisdom interpretation.
Analysing terminal is generated according to detection data and is reported for obtaining detection data from data server, is reported and is lost
Pass on prediction result correlation of declining office, invitation, etc. on account of illness.As shown in figure 3, the specific workflow of analysing terminal is divided into:
1) data detection: population sample Quality Control Analysis is carried out with statistical way to detection data, quality control is closed
Link is analyzed in entering for lattice in next step, and unqualified data need to re-start sampling or reinspection, to guarantee to enter diseases analysis link
Data it is accurate and reliable；
2) data screening: to quality acceptance number, sample is unit accordingly, according to be stored in systemic disease database with
Inherited Metabolic Disorders index of correlation and the other factors index that may influence normal interpretation carry out different with Inherited Metabolic Disorders index of correlation
Category filter whether often；
3) first sentence interpretation: system will test result and match with the essential information of patient, while carry out to testing result preliminary
Interpretation illustrates that newborn is strong if whole indexs, in range of normal value, the preliminary interpretation of testing result is A, index is normal
Health is directly entered output report step, and otherwise, the preliminary interpretation of testing result is B, Indexes Abnormality, enters next node by process
Interpretation；
4) second trial interpretation: by result that first sentence node interpretation is B Indexes Abnormality by the comparison interpretation of index and be
The comparative analysis judgement of system disease database, carries out further interpretation.As shown in Fig. 2, if having 1 or more coupling index not just
In normal reference range, then interpretation is C, related to disease suspicious, is judged into next node；If there is 1 or more disease crucial
Index is not in normal reference value, then interpretation is D, very related to disease, into next node interpretation；
5) a is read in three trials: the progress further accurate interpretation for being C by second trial node interpretation is sentenced by the comparison of index
It reads and judges with the comparative analysis of systemic disease database, health antenatal in conjunction with mother, when producing and nutritional status, newborn
Disease and nutrition condition when blood sampling carry out accurate interpretation.If abnormal index and mother are antenatal, health and nutritional status when producing, new
Nutritional status when raw youngster's blood sampling is related, is judged as E, and prompt is little with hereditary metabolic disorders correlation, is judged as abnormal and mentions
Show that disease probability is low；If there are still have disease indicators exception, and its anomalous variation for situation when excluding mother and newborn's blood sampling
Less, then it is judged as F, prompt may be slight Inherited Metabolic Disorders, can be paid close attention to or be intervened ahead of time.
6) b is read in three trials: second trial node interpretation is classified as D's as a result, by the comparison interpretation and and system of index
The comparative analysis of disease database judges, degree is raised and lowered according to index and combines Clinical signs, carries out accurate interpretation.Refer to
It is very high, interpretation G that degree, which is raised and lowered, or not mark, prompts moderate Inherited Metabolic Disorders；It is bigger that index is raised and lowered degree,
Interpretation is H, prompts severe Inherited Metabolic Disorders.
8) report output: comprehensive by system in conjunction with the essential information of patient, detection data and final diseases analysis suggestion
Examining report display terminal is generated after conjunction to be used to show the examining report generated.
Feedback terminal feeds back Inherited Metabolic Disorders actual result for obtaining Inherited Metabolic Disorders prediction result.Staff according to
Mother and child care network in region is held in the palm, establishes follow-up study network, by the different diagnosis and treatment requirements of screening disease, periodic visit makes a definite diagnosis trouble
The newest health status of infant is updated to data server by feedback terminal by youngster, staff can according to it is different most
Whole interpretation result determines follow-up plan, for example, for three trial read b be in, severe prompt Inherited Metabolic Disorders high risk situation,
It needs to carry out this kind of crowd to make a definite diagnosis tracking after testing result notice, is confirmed whether to be diagnosed as Inherited Metabolic Disorders and be done sth. in advance
Therapy intervention.
Newborn's Inherited Metabolic Disorders testing and analysis system proposed by the present invention divides Testing index by computer system
Analysis compares and the analyses and comparison of disease database, can more accurate interpretation go out the disease directive property of testing result, can be with
It more fast and accurately assists a physician and completes the analysis of testing result and provide analysis and suggestion, avoid doctor and spent by manpower
The a large amount of time carries out the analysis of index and database, saves the time of doctor.At the same time, the system is basic by patient
Information, Testing index, disease database etc. are multiple to be compared repeatedly, and final result is judged by doctor according to clinical manifestation again,
The generation of misinterpretation can be avoided to greatest extent.
Newborn's Inherited Metabolic Disorders testing and analysis system proposed by the present invention has created computer system, disease database
The analysis processing mode that (big data), doctor combine, can be more fast and accurately to newborn's Inherited Metabolic Disorders series connection matter
Spectrum testing result carries out interpretation and provides accurate conclusion.Entire workflow realizes comprehensive data, enables interpretation process
It enough is easier to trace to the source and later period Comparison Study repeatedly, can greatly avoid being looked back because the artificial interpretation later period forgets
Property analysis.This system realizes the automation of higher degree using the mode of man-computer cooperation, so that 2-3 people's coupled system can be complete
The workload completed at 5-10 doctor was needed originally greatly reduces the investment of human cost.With the increasing of data volume
More and system enrich constantly is improved and is optimized, and following newborn's Inherited Metabolic Disorders tandem mass spectrum testing result interpretation is even
The interpretation of Artificial intelligence can be able to achieve.
The above disclosure is only the preferred embodiments of the present invention, cannot limit the right model of the present invention with this certainly
It encloses, therefore equivalent changes made in accordance with the claims of the present invention, is still within the scope of the present invention.
Claims (10)
1. a kind of newborn's Inherited Metabolic Disorders determination method, which is characterized in that described method includes following steps:
S1: sample data is obtained；
S2: distinguishing according to sample data, if Inherited Metabolic Disorders exception, thens follow the steps S3；If non-Inherited Metabolic Disorders
It is abnormal, execute step S6；
S3: first step classification is carried out according to each index primary and secondary degree in all kinds of Inherited Metabolic Disorders metabolic pathways, is obtained for the first time
Classification results；If thening follow the steps S5 without main Indexes Abnormality in first time classification results；It is no to then follow the steps S4；
S4: according to multi objective joint risk assessment classification is carried out, second of classification results is obtained；
S5: comprehensive first time classification results and second of classification results provide final classification of diseases result；S6: terminate.
2. a kind of newborn's Inherited Metabolic Disorders determination method as described in claim 1, which is characterized in that wrapped in the S1
It includes, by Quality Control Analysis method, sample data is analyzed, if sample data is unqualified, carry out resampling or multiple
Inspection, otherwise enters step S2.
3. a kind of newborn's Inherited Metabolic Disorders determination method as described in claim 1, which is characterized in that the tool of the S2
Body implementation are as follows:
S21: the index for influencing Inherited Metabolic Disorders and the factor index that normal interpretation may be influenced are read；
S22: differentiate whether the index in S21 is all normal, if all normal, be determined as that non-Inherited Metabolic Disorders are abnormal, execute
Step S6；Otherwise, Inherited Metabolic Disorders exception is regarded as, step S3 is executed.
4. a kind of newborn's Inherited Metabolic Disorders determination method as described in claim 1, which is characterized in that the tool of the S3
Body implementation are as follows:
S31: certain Inherited Metabolic Disorders being had confirmed that according to clinical research are mainly caused by what Indexes Abnormality, screening and the heredity generation
It declines office, invitation, etc. on account of illness relevant index；
S32: carrying out point of primary and secondary to index, to being main indicator with the index of certain Inherited Metabolic Disorders highlights correlations, loses to certain
Passing on slight associated index of declining office, invitation, etc. on account of illness is secondary index；
S33: distinguishing the effect degree of index in the metabolic process, and the first subseries of data is carried out according to the classification；
Main indicator is raised and lowered if it exists, it is believed that abnormal prompt is very related to disease, and Indexes Abnormality degree and clinic
It characterizes and determines first time classification results；
Otherwise, step S4 is executed.
5. a kind of newborn's Inherited Metabolic Disorders determination method as described in claim 1, which is characterized in that the step S4
Specific implementation are as follows:
Judge by the comparison interpretation of index and with the comparative analysis of systemic disease database, obtain second of classification results,
Disease and nutrition condition when health antenatal in conjunction with mother, when producing and nutritional status, newborn's blood sampling carry out accurate interpretation.If
Nutritional status when abnormal index and mother are antenatal, health and nutritional status, newborn take a blood sample when producing is related, prompts and heredity generation
Thanking property is disease associated less, is judged as that abnormal prompt disease probability is low；If situation when exclusion mother and newborn take a blood sample is still
There are disease indicators exceptions, and its anomalous variation is little, then are judged as to be slight Inherited Metabolic Disorders, can be closed ahead of time
Note is intervened.
6. a kind of newborn's Inherited Metabolic Disorders determination method as described in claim 1, which is characterized in that the step S1
In, pass through the sample data of neonatal bleeding of the umbilicus or vola blood.
7. a kind of newborn's Inherited Metabolic Disorders determination method as described in claim 1, which is characterized in that the step S6
In, before end, according to the cause of disease, corresponding suggestion is provided, and generate report.
8. a kind of newborn's Inherited Metabolic Disorders test and analyze device, which is characterized in that newborn's Inherited Metabolic Disorders detection point
Analysis apparatus carries out the detection and analysis of newborn's Inherited Metabolic Disorders using method described in one of claim 1-7.
9. a kind of newborn's Inherited Metabolic Disorders testing and analysis system, which is characterized in that newborn's Inherited Metabolic Disorders detection point
Analysis system includes data collection station, newborn's Inherited Metabolic Disorders detection and analysis device；
It includes data server, analysing terminal, display terminal that newborn's Inherited Metabolic Disorders, which test and analyze device,；
It is sequentially connected between the data collection station, the data server, the analysing terminal and the display terminal,
Data collection station includes data input module and pattern detection module；
Data server stores newborn's information bank and disease database；
Analysing terminal is generated according to detection data and is reported for obtaining detection data from data server；
Display terminal is used to show the examining report generated；
Newborn's Inherited Metabolic Disorders test and analyze device and carry out newborn's something lost using method described in one of claim 1-7
Pass on detection and analysis of declining office, invitation, etc. on account of illness.
10. a kind of newborn's Inherited Metabolic Disorders testing and analysis system as claimed in claim 9, which is characterized in that the new life
Youngster's Inherited Metabolic Disorders testing and analysis system includes feedback terminal, and electric signal connects between the analysing terminal and the feedback terminal
It connects；
Feedback terminal feeds back Inherited Metabolic Disorders actual result for obtaining Inherited Metabolic Disorders prediction result.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910597264.2A CN110322963B (en) | 2019-07-04 | 2019-07-04 | Neonatal genetic metabolic disease detection and analysis method, device and system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910597264.2A CN110322963B (en) | 2019-07-04 | 2019-07-04 | Neonatal genetic metabolic disease detection and analysis method, device and system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110322963A true CN110322963A (en) | 2019-10-11 |
| CN110322963B CN110322963B (en) | 2024-01-30 |
Family
ID=68122548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910597264.2A Active CN110322963B (en) | 2019-07-04 | 2019-07-04 | Neonatal genetic metabolic disease detection and analysis method, device and system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110322963B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112331284A (en) * | 2020-10-27 | 2021-02-05 | 复旦大学附属儿科医院 | Admission medical history auxiliary acquisition system for hereditary metabolic disease |
| CN116189907A (en) * | 2022-12-05 | 2023-05-30 | 广州盛安医学检验有限公司 | Intelligent genetic metabolic disease screening system suitable for newborns |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002057989A2 (en) * | 2001-01-18 | 2002-07-25 | Basf Aktiengesellschaft | Method for metabolic profiling |
| CA2885834A1 (en) * | 2012-09-27 | 2014-04-03 | The Children's Mercy Hospital | System for genome analysis and genetic disease diagnosis |
| CN104123368A (en) * | 2014-07-24 | 2014-10-29 | 中国软件与技术服务股份有限公司 | Big data attribute significance and recognition degree early warning method and system based on clustering |
| CN105044361A (en) * | 2015-08-14 | 2015-11-11 | 山东省肿瘤防治研究院 | Diagnosis marker suitable for early-stage esophageal squamous cell cancer diagnosis and screening method of diagnosis marker |
| US20160017412A1 (en) * | 2014-07-18 | 2016-01-21 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular dna and cell free dna |
| WO2017086675A1 (en) * | 2015-11-19 | 2017-05-26 | 연세대학교 산학협력단 | Apparatus for diagnosing metabolic abnormalities and method therefor |
| CN107038337A (en) * | 2017-03-21 | 2017-08-11 | 广州华康基因医学科技有限公司 | A kind of neonate's Inherited Metabolic Disorders screening method |
| CN108877936A (en) * | 2018-04-28 | 2018-11-23 | 见道（杭州）科技有限公司 | Health evaluating method, system and computer readable storage medium |
| CN109086571A (en) * | 2018-08-03 | 2018-12-25 | 国家卫生计生委科学技术研究所 | A kind of method and system that monogenic disease hereditary variation is intelligently interpreted and reported |
-
2019
- 2019-07-04 CN CN201910597264.2A patent/CN110322963B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002057989A2 (en) * | 2001-01-18 | 2002-07-25 | Basf Aktiengesellschaft | Method for metabolic profiling |
| CA2885834A1 (en) * | 2012-09-27 | 2014-04-03 | The Children's Mercy Hospital | System for genome analysis and genetic disease diagnosis |
| US20160017412A1 (en) * | 2014-07-18 | 2016-01-21 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular dna and cell free dna |
| CN104123368A (en) * | 2014-07-24 | 2014-10-29 | 中国软件与技术服务股份有限公司 | Big data attribute significance and recognition degree early warning method and system based on clustering |
| CN105044361A (en) * | 2015-08-14 | 2015-11-11 | 山东省肿瘤防治研究院 | Diagnosis marker suitable for early-stage esophageal squamous cell cancer diagnosis and screening method of diagnosis marker |
| WO2017086675A1 (en) * | 2015-11-19 | 2017-05-26 | 연세대학교 산학협력단 | Apparatus for diagnosing metabolic abnormalities and method therefor |
| CN107038337A (en) * | 2017-03-21 | 2017-08-11 | 广州华康基因医学科技有限公司 | A kind of neonate's Inherited Metabolic Disorders screening method |
| CN108877936A (en) * | 2018-04-28 | 2018-11-23 | 见道（杭州）科技有限公司 | Health evaluating method, system and computer readable storage medium |
| CN109086571A (en) * | 2018-08-03 | 2018-12-25 | 国家卫生计生委科学技术研究所 | A kind of method and system that monogenic disease hereditary variation is intelligently interpreted and reported |
Non-Patent Citations (3)
| Title |
|---|
| 张雯艳;朱颖杰;万立新;侯祥;: "新生儿串联质谱扩展筛查认知情况及影响因素分析", 中国妇幼保健, vol. 30, no. 31, pages 5493 - 5495 * |
| 曾伟宏;欧阳海梅;谢汛杰;袁莹;梁金群;陈暖;刘舒;韦思思;陈丽莹;江剑辉;: "血液3-羟基异戊酰肉碱增高的遗传代谢疾病分析及其阈值的建立", 广东医学, vol. 39, no. 19, pages 2885 - 2889 * |
| 王玲;袁雪莲;陈建;万华靖;李佳圆;王梅;: "出生体质量对新生儿遗传代谢病相关指标的影响", 中国妇幼保健, vol. 34, no. 07, pages 1599 - 1603 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112331284A (en) * | 2020-10-27 | 2021-02-05 | 复旦大学附属儿科医院 | Admission medical history auxiliary acquisition system for hereditary metabolic disease |
| CN116189907A (en) * | 2022-12-05 | 2023-05-30 | 广州盛安医学检验有限公司 | Intelligent genetic metabolic disease screening system suitable for newborns |
| CN116189907B (en) * | 2022-12-05 | 2023-09-05 | 广州盛安医学检验有限公司 | Intelligent genetic metabolic disease screening system suitable for newborns |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110322963B (en) | 2024-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arts et al. | Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry | |
| Sachse et al. | Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes | |
| CN110141220B (en) | Myocardial infarction automatic detection system based on multi-mode fusion neural network | |
| Kiss et al. | Stress transgenerationally programs metabolic pathways linked to altered mental health | |
| US8175816B2 (en) | System and method for analyzing metabolomic data | |
| CN112786204A (en) | Machine learning diabetes onset risk prediction method and application | |
| WO2018049268A1 (en) | Biomarkers for the diagnosis and characterization of alzheimer's disease | |
| CA2641131A1 (en) | A method of diagnosing a respiratory disease | |
| CN112786203A (en) | Machine learning diabetic retinopathy morbidity risk prediction method and application | |
| CN106202968A (en) | The data analysing method of cancer and device | |
| CN110322963A (en) | A kind of newborn's Inherited Metabolic Disorders determination method, apparatus and system | |
| CN112837821A (en) | Method and system for identifying abnormal cases in case diagnosis grouping | |
| CN110379459A (en) | A kind of method and system being associated with discovery molecular marker with gene function based on transcript profile dynamic change of temporal series | |
| CN107209189A (en) | Quick screening and evaluation by glycosylated hemoglobin mass spectrum to diabetes and prediabetes | |
| Ott et al. | Construct validity of the NIH toolbox cognitive domains: A comparison with conventional neuropsychological assessments. | |
| CN115331803A (en) | Construction method and system for predicting ovarian hyporesponsiveness and deploying individualized ovarian stimulation strategy model | |
| Wei et al. | Applying dimensional psychopathology: transdiagnostic prediction of executive cognition using brain connectivity and inflammatory biomarkers | |
| CN116130105A (en) | Health risk prediction method based on neural network | |
| Huang et al. | Traditional Chinese medicine constitution discrimination model based on metabolomics and random forest decision tree algorithm | |
| Eilers | Quality assurance in health care: missions, goals, activities | |
| Siddiqui et al. | Food for thought: machine learning in autism Spectrum disorder screening of infants | |
| Helfand et al. | Harmonization of four delirium instruments: creating crosswalks and the delirium item-bank (DEL-IB) | |
| Maddipatla | Classaphasia: an ensemble machine learning network to improve aphasia diagnosis and determine severity | |
| Hubbard et al. | Evaluation of visual-evoked cerebral metabolic rate of oxygen as a diagnostic marker in multiple sclerosis | |
| Williams et al. | Preliminary analysis of sodium-lithium countertransport and blood pressure in Utah pedigrees |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20240103 Address after: Room 401, Building 1, No. 5 Gaopeng Avenue, High tech Zone, Chengdu City, Sichuan Province, 610000 Applicant after: CHENGDU NEW GENEGLE BIOTECHNOLOGY CO.,LTD. Applicant after: CHENGDU GENEGLE MEDICAL LABORATORY Co.,Ltd. Address before: Room 401, Building 1, No. 5 Gaopeng Avenue, High tech Zone, Chengdu City, Sichuan Province, 610000 Applicant before: CHENGDU NEW GENEGLE BIOTECHNOLOGY CO.,LTD. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |